1. Home
  2. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY

Author/s: 
Garber, A.J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M.J., Barzilay, J.I., Blonde, L., Bush, M.A.
Date Added: 
November 19, 2020
Journal/Publication: 
Endocrine Practice
Publication Date: 
January 1, 2020
Issue: 
1
Volume: 
26
URL: 
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY
Type: 
Meta-analyses, Reviews, and Guidelines
Format: 
Article
DOI (1): 
10.4158/CS-2019-0472
MeSH 
diabetes mellitus
Algorithms
Consensus
Endocrinologists
Endocrinology
diabetes mellitus, type 2

RPR Commentary

This consensus statement includes a helpful algorithm for medication management of patients with Type diabetes based upon their other health challenges.  James W. Mold, MD, MPH

Abstract

No abstract available.

Text Availability

Commercial full text (fees may apply)